| Bioactivity | Ferroptosis-IN-11 (compound 43) is a ferroptosis inhibitor. Ferroptosis-IN-11 can inhibit Erastin (HY-15763) induced ferroptosis in HT-1080 human fibroblasts (EC50=36 nM). Ferroptosis-IN-11 can be used in the study of cardiovascular disease and neurodegeneration[1]. |
| CAS | 1266755-01-4 |
| Formula | C14H12F2N2 |
| Molar Mass | 246.26 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. HongXu Lei, et al. "A quantum-chemical approach to develop tetrahydroquinoxaline as potent ferroptosis inhibitors." Journal of Molecular Structure 1228 (2021): 129485. |
Ferroptosis-IN-11
CAS: 1266755-01-4 F: C14H12F2N2 W: 246.26
Ferroptosis-IN-11 (compound 43) is a ferroptosis inhibitor. Ferroptosis-IN-11 can inhibit Erastin (HY-15763) induced fer
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.